164 related articles for article (PubMed ID: 28539530)
1. Active form of vitamin D ameliorates non-alcoholic fatty liver disease by alleviating oxidative stress in a high-fat diet rat model.
Zhu CG; Liu YX; Wang H; Wang BP; Qu HQ; Wang BL; Zhu M
Endocr J; 2017 Jul; 64(7):663-673. PubMed ID: 28539530
[TBL] [Abstract][Full Text] [Related]
2. Hesperetin ameliorates hepatic oxidative stress and inflammation
Li J; Wang T; Liu P; Yang F; Wang X; Zheng W; Sun W
Food Funct; 2021 May; 12(9):3898-3918. PubMed ID: 33977953
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D attenuates high fat diet-induced hepatic steatosis in rats by modulating lipid metabolism.
Yin Y; Yu Z; Xia M; Luo X; Lu X; Ling W
Eur J Clin Invest; 2012 Nov; 42(11):1189-96. PubMed ID: 22958216
[TBL] [Abstract][Full Text] [Related]
4. Salidroside alleviates oxidative stress in the liver with non- alcoholic steatohepatitis in rats.
Yang ZR; Wang HF; Zuo TC; Guan LL; Dai N
BMC Pharmacol Toxicol; 2016 Apr; 17():16. PubMed ID: 27075663
[TBL] [Abstract][Full Text] [Related]
5. Exendin-4, a glucagon-like peptide-1 receptor agonist downregulates hepatic receptor for advanced glycation end products in non-alcoholic steatohepatitis rat model.
Allam MM; El Gazzar WB
Arch Physiol Biochem; 2018 Feb; 124(1):10-17. PubMed ID: 28696785
[TBL] [Abstract][Full Text] [Related]
6. Regressive Effect of Myricetin on Hepatic Steatosis in Mice Fed a High-Fat Diet.
Xia SF; Le GW; Wang P; Qiu YY; Jiang YY; Tang X
Nutrients; 2016 Dec; 8(12):. PubMed ID: 27973423
[TBL] [Abstract][Full Text] [Related]
7. Lipoic Acid Prevents High-Fat Diet-Induced Hepatic Steatosis in Goto Kakizaki Rats by Reducing Oxidative Stress Through Nrf2 Activation.
Sena CM; Cipriano MA; Botelho MF; Seiça RM
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30208622
[TBL] [Abstract][Full Text] [Related]
8. 1,25(OH)2D3 downregulates the Toll-like receptor 4-mediated inflammatory pathway and ameliorates liver injury in diabetic rats.
Wang H; Zhang Q; Chai Y; Liu Y; Li F; Wang B; Zhu C; Cui J; Qu H; Zhu M
J Endocrinol Invest; 2015 Oct; 38(10):1083-91. PubMed ID: 25906757
[TBL] [Abstract][Full Text] [Related]
9. Scutellarin Prevents Nonalcoholic Fatty Liver Disease (NAFLD) and Hyperlipidemia via PI3K/AKT-Dependent Activation of Nuclear Factor (Erythroid-Derived 2)-Like 2 (Nrf2) in Rats.
Fan H; Ma X; Lin P; Kang Q; Zhao Z; Wang L; Sun D; Cheng J; Li Y
Med Sci Monit; 2017 Nov; 23():5599-5612. PubMed ID: 29172017
[TBL] [Abstract][Full Text] [Related]
10. Dietary creatine supplementation lowers hepatic triacylglycerol by increasing lipoprotein secretion in rats fed high-fat diet.
da Silva RP; Leonard KA; Jacobs RL
J Nutr Biochem; 2017 Dec; 50():46-53. PubMed ID: 29031242
[TBL] [Abstract][Full Text] [Related]
11. Sugary Kefir Strain Lactobacillus mali APS1 Ameliorated Hepatic Steatosis by Regulation of SIRT-1/Nrf-2 and Gut Microbiota in Rats.
Chen YT; Lin YC; Lin JS; Yang NS; Chen MJ
Mol Nutr Food Res; 2018 Apr; 62(8):e1700903. PubMed ID: 29508520
[TBL] [Abstract][Full Text] [Related]
12. Experimental nonalcoholic fatty liver disease in mice leads to cytochrome p450 2a5 upregulation through nuclear factor erythroid 2-like 2 translocation.
Cui Y; Wang Q; Li X; Zhang X
Redox Biol; 2013; 1(1):433-40. PubMed ID: 24191237
[TBL] [Abstract][Full Text] [Related]
13. Niga-ichigoside F1 ameliorates high-fat diet-induced hepatic steatosis in male mice by Nrf2 activation.
Xia SF; Shao J; Zhao SY; Qiu YY; Teng LP; Huang W; Wang SS; Cheng XR; Jiang YY
Food Funct; 2018 Feb; 9(2):906-916. PubMed ID: 29309075
[TBL] [Abstract][Full Text] [Related]
14. Caffeine affects HFD-induced hepatic steatosis by multifactorial intervention.
Helal MG; Ayoub SE; Elkashefand WF; Ibrahim TM
Hum Exp Toxicol; 2018 Sep; 37(9):983-990. PubMed ID: 29249184
[TBL] [Abstract][Full Text] [Related]
15. Chicoric Acid Ameliorates Nonalcoholic Fatty Liver Disease via the AMPK/Nrf2/NF
Ding X; Jian T; Li J; Lv H; Tong B; Li J; Meng X; Ren B; Chen J
Oxid Med Cell Longev; 2020; 2020():9734560. PubMed ID: 33204402
[TBL] [Abstract][Full Text] [Related]
16. Liraglutide Ameliorates Lipotoxicity-Induced Oxidative Stress by Activating the NRF2 Pathway in HepG2 Cells.
Zhu CG; Luo Y; Wang H; Li JY; Yang J; Liu YX; Qu HQ; Wang BL; Zhu M
Horm Metab Res; 2020 Jul; 52(7):532-539. PubMed ID: 32375182
[TBL] [Abstract][Full Text] [Related]
17. 1,2,3,4,6 penta-O-galloyl-β-D-glucose ameliorates high-fat diet-induced nonalcoholic fatty liver disease and maintains the expression of genes involved in lipid homeostasis in mice.
Kant R; Lu CK; Nguyen HM; Hsiao HH; Chen CJ; Hsiao HP; Lin KJ; Fang CC; Yen CH
Biomed Pharmacother; 2020 Sep; 129():110348. PubMed ID: 32554245
[TBL] [Abstract][Full Text] [Related]
18. PSA controls hepatic lipid metabolism by regulating the NRF2 signaling pathway.
Huang B; Xiong X; Zhang L; Liu X; Wang Y; Gong X; Sang Q; Lu Y; Qu H; Zheng H; Zheng Y
J Mol Cell Biol; 2021 Oct; 13(7):527-539. PubMed ID: 34048566
[TBL] [Abstract][Full Text] [Related]
19. Apigenin, a modulator of PPARγ, attenuates HFD-induced NAFLD by regulating hepatocyte lipid metabolism and oxidative stress via Nrf2 activation.
Feng X; Yu W; Li X; Zhou F; Zhang W; Shen Q; Li J; Zhang C; Shen P
Biochem Pharmacol; 2017 Jul; 136():136-149. PubMed ID: 28414138
[TBL] [Abstract][Full Text] [Related]
20. Liensinine alleviates high fat diet (HFD)-induced non-alcoholic fatty liver disease (NAFLD) through suppressing oxidative stress and inflammation via regulating TAK1/AMPK signaling.
Liang L; Ye S; Jiang R; Zhou X; Zhou J; Meng S
Int Immunopharmacol; 2022 Mar; 104():108306. PubMed ID: 34999396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
